Evidence map›Paper›PMID 29887326›Full record

ArticleVaccine2018

Protection by universal influenza vaccine is mediated by memory CD4 T cells.

Sophie A Valkenburg, Olive T W Li, Athena Li, Maireid Bull, Thomas A Waldmann, Liyanage P Perera, Malik Peiris, Leo L M Poon

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Vaccine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04122222 (Immune Response to Influenza Vaccination in ESRD Patients Undergoing Hemodialysis vs. Hemodiafiltration), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04122222 nacompletednot on this map

Immune Response to Influenza Vaccination in ESRD Patients Undergoing Hemodialysis vs. Hemodiafiltration

TypeinterventionalSponsorMahidol UniversityRan2016 to 2018Enrolled60ConditionsImmunology, NephrologyArmsInfluenza vaccine
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Depletion of CD8Transboundary and emerging diseases · 2021
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. CD4Cell reports · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Sophie A ValkenburgHKU Pasteur Research Pole, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region.
Olive T W LiCenter of Influenza Research, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region.
Athena LiHKU Pasteur Research Pole, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region.
Maireid BullHKU Pasteur Research Pole, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region.
Thomas A WaldmannLymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1374, USA.
Liyanage P PereraLymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1374, USA.
Malik PeirisCenter of Influenza Research, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region.
Leo L M PoonCenter of Influenza Research, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: llmpoon@hku.hk.
University of Hong Kong · HKHKU-Pasteur Research Pole · HKNational Cancer Institute · USNational Institutes of Health · US

Funding

IL-2:IL-15 : implications for cancer therapy (Investigator -Initiated Project)ZIASC004002 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI WALDMANN, THOMAS · 2009 to 2022
$22.9M
Interleukin-15 Production for Treatment of Patients with Metastatic MalignancyZ01BC010906 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WALDMANN, THOMAS · 2008 to 2008
$2.0M
Intramural NIH HHS Z01 BC010906Intramural NIH HHS ZIA SC004002NIAID NIH HHS HHSN272201400006C
6 · The paper itself

Abstract

There is a diverse array of influenza viruses which circulate between different species, reassort and drift over time. Current seasonal influenza vaccines are ineffective in controlling these viruses. We have developed a novel universal vaccine which elicits robust T cell responses and protection against diverse influenza viruses in mouse and human models. Vaccine mediated protection was dependent on influenza-specific CD4

Indexed as

Immunologic MemoryAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFemaleInfluenza VaccinesMice, Inbred BALB CMice, NudeMice, SCIDSurvival AnalysisInfluenza VaccinesIL-15Influenza virusT cellsUniversal vaccineVaccinia

Identifiers

PMID29887326
PMCPMC8127355
OpenAlexW2806209855

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.